本页面由Tiger Trade Technology Pte. Ltd.提供服务

Mirum Pharmaceuticals, Inc.

96.72
+0.41000.43%
盘后96.720.00000.00%16:10 EDT
成交量:36.67万
成交额:3,553.11万
市值:62.80亿
市盈率:-6.87
高:97.85
开:96.31
低:95.49
收:96.31
52周最高:130.00
52周最低:63.23
股本:6,493.22万
流通股本:5,641.51万
量比:0.71
换手率:0.65%
股息:- -
股息率:- -
每股收益(TTM):-14.0800
每股收益(LYR):-0.4700
净资产收益率:-702.97%
总资产收益率:-6.79%
市净率:-602.59
市盈率(LYR):-205.79

数据加载中...

2026/08/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/13

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/06

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/05

重要事件披露

Form 8-K - Current report
2026/08/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/18

重要事件披露

Form 8-K - Current report
2026/06/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/18

重要事件披露

Form 8-K - Current report
2026/05/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/06

重要事件披露

Form 8-K - Current report
2026/05/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]